SRC and age-related macular degeneration: When supplied in the form of eye drops, 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate, a prodrug with thermal stability, was readily converted to 4-chloro-3-{5-methyl-3-[4-(2-pyrrolidin-1-yl-ethoxy)phenylamino]benzo[1,2,4]triazin-7-yl}phenol, an active compound that could inhibit the VEGFr2 and Src family (Src and YES) kinase signaling pathways for the treatment of AMD [48].